Ranch Capital Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,424
Closed -$276K 893
2021
Q1
$276K Sell
1,424
-344
-19% -$69K 0.18% 129
2020
Q4
$375K Buy
1,768
+106
+6% +$21.1K 0.27% 99
2020
Q3
$293K Buy
1,662
+14
+0.8% +$2.58K 0.24% 107
2020
Q2
$288K Buy
1,648
+375
+29% +$61.4K 0.23% 113
2020
Q1
$187K Buy
1,273
+1,250
+5,435% +$199K 0.19% 121
2019
Q4
$4K Buy
+23
New +$3.31K ﹤0.01% 822

Other funds holding RMD

Ranch Capital Advisors's RMD Position: Q2 2021 in Review

Ranch Capital Advisors sold out of ResMed (RMD) in Q2 2021, closing a stake of 1,424 shares — an estimated $276K sold.

Ranch Capital Advisors first reported a position in RMD in Q4 2019 and held it in 6 quarters. The position peaked at $375K in Q4 2020. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Ranch Capital Advisors reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Ranch Capital Advisors sold 1,424 ResMed shares in Q2 2021, an estimated $276K.
  • Ranch Capital Advisors first reported a position in ResMed in Q4 2019 and held it in 6 quarters.
  • Ranch Capital Advisors's ResMed position peaked at $375K in Q4 2020.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Ranch Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.